Stock data
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI) reported net income of -US$19.91M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$20.24M | -US$19.91M | — |
| 2024 | — | — | -US$21.78M | -US$22.14M | — |
| 2023 | — | — | -US$28.99M | -US$29.22M | — |
| 2022 | US$0.04M | — | -US$23.13M | -US$25.43M | — |
| 2021 | — | — | -US$1.78M | US$3.39M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.16M | — |
| 2026-03-31 | — | -US$4.11M | — |
| 2025-12-31 | — | -US$4.06M | — |
| 2025-09-30 | — | -US$5.15M | — |
| 2025-06-30 | — | -US$5.71M | — |
| 2025-03-31 | — | -US$4.99M | — |
| 2024-12-31 | — | -US$4.10M | — |
| 2024-09-30 | — | -US$5.05M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.